MAPT and neoplasm: It is likely that each form of tau contributes in a unique way to survival and proliferation of HGSOC cells as its global reduction by either genomic (siRNA) or pharmacological (tau degradation) approaches significantly impacted cell viability, proliferation, and tumor formation.